Morphocell Technologies Inc.

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Morphocell Technologies is a preclinical regenerative medicine company focused on the commercialization of innovative stem cell therapies aimed at treating severe liver disease. Morphocell is developing an extensive therapeutic platform based on its allogeneic pluripotent stem cell-derived engineered liver tissues. With substantial pre-seed funding and strong partnerships, we significantly de-risked the technology, collected compelling in vivo efficacy and safety data and addressed key scalability hurdles in manufacturing. We are now fundraising to continue our journey toward a first-in-human clinical trial.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Quebec
Company HQ Country:
Canada
Year Founded:
2018
Main Therapeutic Focus:
Lead Product in Development:
ReLiver - Encapsulated Liver Tissue
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2
Speaker
photo
Founder, CEO
Morphocell Technologies Inc.